SORATIB 200 mg (Sorafenib IP) is an oral targeted cancer medication. Manufactured by Samarth Life Sciences, it inhibits multiple kinases to treat advanced liver cancer (hepatocell…
SORATIB 200 mg (Sorafenib IP) is an oral targeted cancer medication. Manufactured by Samarth Life Sciences, it inhibits multiple kinases to treat advanced liver cancer (hepatocellular carcinoma), kidney cancer (renal cell carcinoma), and thyroid cancer. It acts by cutting off the blood supply that tumor cells need to multiply.
liketo.usa,uk,china,southkorea,russia,japan,singapore
Strength 200 mg
Packaging Size 30 Tablets
Form Tablet
Country of Origin Made in India
Usage/Application Clinic
Manufacturer Samarth
Brand Soratib
Packaging Type Bottle
Composition Sorafenib Tablets IP
Minimum order quantity: 50 Bottle
Composition details not available.
We offer reliable delivery across India and international markets. Domestic orders typically arrive within 5–7 business days. International shipping times vary by destination. All orders are carefully packaged to maintain product integrity and quality.
